Treatment success in relation to timing of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss
Diving and Hyperbaric Medicine Journal · 31.03.2026 · 56 (1) · 41-47
DOI: 10.28920/dhm56.1.41-47 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diving and Hyperbaric Medicine Journal, online erschienen am 31.03.2026. Verfasst von Cheuk-Yin Lun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Accident and Emergency Department, Queen Elizabeth Hospital, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Hearing Loss, Sudden, Hearing Loss, Sensorineural. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Idiopathic sudden sensorineural hearing loss (ISSNHL) is an otologic emergency for which hyperbaric oxygen therapy (HBOT) is a potential treatment. This study aimed to evaluate the effectiveness of HBOT in treating ISSNHL, with a focus on the timing of treatment and its impact on hearing outcomes, while also considering other factors such as demographic characteristics, clinical parameters, and treatment methods.
Methods
This retrospective cohort study analysed 70 ISSNHL patients (April 2019 to August 2024) who received steroid treatment (oral, intratympanic or both). Patients were divided into early HBOT (< 12 days), late HBOT (13–22 days), salvage HBOT (> 22 days), and no HBOT groups. Hearing improvement, measured by pure-tone audiometry (PTA), defined the treatment outcome.
Results
Significant PTA improvements were observed in most groups (median changes: early HBOT 33.8 dB [n = 15], late HBOT 6.9 dB [n = 16], salvage HBOT 0.0 dB [n = 5], no HBOT 11.9 dB [n = 34]), with early HBOT showing greater gains than late HBOT (P < 0.001), salvage HBOT (P = 0.001), and no HBOT (P = 0.002). Receiver operating characteristic (ROC) analysis indicated that treatment within 10.5 days predicted marked improvement (AUC = 0.883, P < 0.001), and linear regression showed that each day’s delay reduced PTA improvement by 0.832 dB (P < 0.001).
Conclusions
HBOT is effective in restoring hearing in patients suffering from ISSNHL and early treatment is associated with better outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Accident and Emergency Department, Queen Elizabeth Hospital, Hong Kong SAR, China.
- Corresponding author: Dr Cheuk-Yin Lun, Accident and Emergency Department, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong SAR, China, cylun1006@gmail.com.
- Department of Ear, Nose and Throat, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
- Hyperbaric Oxygen Therapy Centre, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
Zitieren
APA
Lun, C. Y., Au Yeung, K. L., Lau, Y. F., Yan, W. W., & Tang, K. B. (2026). Treatment success in relation to timing of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss. Diving and Hyperbaric Medicine Journal, 56(1), 41-47. https://doi.org/10.28920/dhm56.1.41-47
Vancouver
Lun CY, Au Yeung KL, Lau YF, Yan WW, Tang KB. Treatment success in relation to timing of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss. Diving and Hyperbaric Medicine Journal. 2026;56(1):41-47. doi:10.28920/dhm56.1.41-47
BibTeX
@article{Lun2026,
author = {Lun, Cheuk-Yin and Au Yeung, Kwan-Leong and Lau, Yuk-Fai and Yan, Wing-Wa and Tang, Kin-Bong},
title = {Treatment success in relation to timing of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss},
journal = {Diving and Hyperbaric Medicine Journal},
year = {2026},
volume = {56},
number = {1},
pages = {41--47},
doi = {10.28920/dhm56.1.41-47}
}
EUVIMED